Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

LXR's patented drug screening technology yields two novel apoptosis-suppressing agents

Nov. 18, 1997

No Comments

Second drug from Inhale/Baxter collaboration enters clinical testing

Nov. 13, 1997

No Comments

LeukoSite, Warner-Lambert and Kyowa Hakko chemokine drug discovery collaboration

Nov. 13, 1997

No Comments

ICAgen receive SBIR grant for ion channel drug target research

Nov. 11, 1997

No Comments

Proof of principle demonstrated for Titan's drug delivery system

Nov. 11, 1997

No Comments

Myriad creates CNS database for potential drug discovery

Nov. 7, 1997

No Comments

U.S. patent issued for Cambridge NeuroScience's drug delivery system

Nov. 6, 1997

No Comments

Genetronics cleared to proceed with electroporation trial in France

Nov. 6, 1997

No Comments

CellPro: Q2 1997 highlights

Nov. 6, 1997

No Comments

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

LXR's patented drug screening technology yields two novel apoptosis-suppressing agents

Second drug from Inhale/Baxter collaboration enters clinical testing

LeukoSite, Warner-Lambert and Kyowa Hakko chemokine drug discovery collaboration

ICAgen receive SBIR grant for ion channel drug target research

Proof of principle demonstrated for Titan's drug delivery system

Myriad creates CNS database for potential drug discovery

U.S. patent issued for Cambridge NeuroScience's drug delivery system

Genetronics cleared to proceed with electroporation trial in France

CellPro: Q2 1997 highlights

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Radiopharma Telix acquires FAP-targeting agents for bladder cancer

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS